600 related articles for article (PubMed ID: 23661044)
1. Role of subconjunctival bevacizumab as an adjuvant to primary trabeculectomy: a prospective randomized comparative 1-year follow-up study.
Akkan JU; Cilsim S
J Glaucoma; 2015 Jan; 24(1):1-8. PubMed ID: 23661044
[TBL] [Abstract][Full Text] [Related]
2. Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy.
Nilforushan N; Yadgari M; Kish SK; Nassiri N
Am J Ophthalmol; 2012 Feb; 153(2):352-357.e1. PubMed ID: 21982106
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Adjunctive Subconjunctival Bevacizumab on the Outcomes of Primary Trabeculectomy With Mitomycin C: A Prospective Randomized Placebo-controlled Trial.
Kiddee W; Orapiriyakul L; Kittigoonpaisan K; Tantisarasart T; Wangsupadilok B
J Glaucoma; 2015; 24(8):600-6. PubMed ID: 25393038
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Bevacizumab Compared to Mitomycin C Modulated Trabeculectomy in Primary Open Angle Glaucoma: A One-Year Prospective Randomized Controlled Study.
Kaushik J; Parihar JK; Jain VK; Gupta S; Nath P; Durgapal P; Ram J
Curr Eye Res; 2017 Feb; 42(2):217-224. PubMed ID: 27269279
[TBL] [Abstract][Full Text] [Related]
5. Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab Versus Mitomycin C: A Randomized Controlled Trial.
Vahedian Z; Mafi M; Fakhraie G; Zarei R; Eslami Y; Ghadimi H; Mohebbi M
J Glaucoma; 2017 Sep; 26(9):829-834. PubMed ID: 28777224
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up.
Cillino S; Casuccio A; Di Pace F; Cagini C; Ferraro LL; Cillino G
BMC Ophthalmol; 2016 Mar; 16():24. PubMed ID: 26946419
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot study.
Grewal DS; Jain R; Kumar H; Grewal SP
Ophthalmology; 2008 Dec; 115(12):2141-2145.e2. PubMed ID: 18692246
[TBL] [Abstract][Full Text] [Related]
8. Two-year outcome of repeat trabeculectomy with mitomycin C in primary open-angle and PEX glaucoma.
Meyer LM; Graf NE; Philipp S; Fischer MT; Haller K; Distelmaier P; Schönfeld CL
Eur J Ophthalmol; 2015; 25(3):185-91. PubMed ID: 25449638
[TBL] [Abstract][Full Text] [Related]
9. Needle bleb revision with bevacizumab and mitomycin C compared with mitomycin C alone for failing filtration blebs.
Tai TY; Moster MR; Pro MJ; Myers JS; Katz LJ
J Glaucoma; 2015; 24(4):311-5. PubMed ID: 25826644
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the use of 5-fluorouracil and bevacizumab in primary trabeculectomy: results at 1 year.
Jurkowska-Dudzińska J; Kosior-Jarecka E; Zarnowski T
Clin Exp Ophthalmol; 2012; 40(4):e135-42. PubMed ID: 21668792
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the long-term efficacy of short-duration 0.1 mg/ml and 0.2 mg/ml MMC in primary trabeculectomy for primary adult glaucoma.
Sihota R; Angmo D; Chandra A; Gupta V; Sharma A; Pandey RM
Graefes Arch Clin Exp Ophthalmol; 2015 Jul; 253(7):1153-9. PubMed ID: 25940554
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trial.
Sengupta S; Venkatesh R; Ravindran RD
J Glaucoma; 2012 Sep; 21(7):450-9. PubMed ID: 21543993
[TBL] [Abstract][Full Text] [Related]
13. Evaluation the adjunctive use of combined bevacizumab and mitomycinc to trabeculectomy in management of recurrent pediatric glaucoma.
Mahdy RA; Al-Mosallamy SM; Al-Aswad MA; Bor'i A; El-Haig WM
Eye (Lond); 2016 Jan; 30(1):53-8. PubMed ID: 26427987
[TBL] [Abstract][Full Text] [Related]
14. The size of subconjunctival preparation does not influence the outcome of trabeculectomy with mitomycin C.
Wasielica-Poslednik J; Hoffmann EM; Herzog D; Aliyeva S; Lamparter J; Pfeiffer N
J Glaucoma; 2015; 24(5):e75-9. PubMed ID: 25304277
[TBL] [Abstract][Full Text] [Related]
15. Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab: A Randomized Controlled Trial.
Fakhraie G; Ghadimi H; Eslami Y; Zarei R; Mohammadi M; Vahedian Z; Mafi M; Moghimi S
J Glaucoma; 2016 Mar; 25(3):e182-8. PubMed ID: 25493621
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous use of amniotic membrane and Mitomycin C in trabeculectomy for primary glaucoma.
Yadava U; Jaisingh K; Dangda S; Thacker P; Singh K; Goel Y
Indian J Ophthalmol; 2017 Nov; 65(11):1151-1155. PubMed ID: 29133641
[TBL] [Abstract][Full Text] [Related]
17. Smaller-incision Revision of Trabeculectomy With Mitomycin: Long-term Outcomes and Complications.
Chen PP; Moeller KL
J Glaucoma; 2019 Jan; 28(1):27-31. PubMed ID: 30394979
[TBL] [Abstract][Full Text] [Related]
18. The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis.
Elgin U; Sen E; Ozdemir K; Ozdal P; Berker N
Int Ophthalmol; 2020 Apr; 40(4):795-802. PubMed ID: 31792855
[TBL] [Abstract][Full Text] [Related]
19. Mitomycin C-augmented trabeculectomy: subtenon injection versus soaked sponges: a randomised clinical trial.
Pakravan M; Esfandiari H; Yazdani S; Douzandeh A; Amouhashemi N; Yaseri M; Pakravan P
Br J Ophthalmol; 2017 Sep; 101(9):1275-1280. PubMed ID: 28100482
[TBL] [Abstract][Full Text] [Related]
20. Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study.
Ollikainen ML; Puustjärvi TJ; Rekonen PK; Uusitalo HM; Teräsvirta ME
Acta Ophthalmol; 2011 Sep; 89(6):548-55. PubMed ID: 19925527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]